-
2
-
-
84997687735
-
The worst of both worlds: The Wild West of the legal marijuana industry
-
Scheuer LM. The worst of both worlds: The Wild West of the legal marijuana industry. North Ill Univ Law Rev. 2015;35(3):557-574.
-
(2015)
North Ill Univ Law Rev
, vol.35
, Issue.3
, pp. 557-574
-
-
Scheuer, L.M.1
-
3
-
-
84997657728
-
-
1bn a year, lib dem review group says Updated March 8 2016 Accessed June 19, 2016
-
Waugh P. Legalising cannabis and selling it over the counter could raise 1bn a year, lib dem review group says. http://www.huffingtonpost.co.uk/2016/03/07/legalise-cannabis-liberal-democrats-Tim-farron-mike-barton-david-nutt-n-9404346.html. Updated March 8, 2016. Accessed June 19, 2016.
-
Legalising Cannabis and Selling It over the Counter Could Raise
-
-
Waugh, P.1
-
5
-
-
84871070051
-
Common values in assessing health outcomes from disease and injury: Disabilityweights measurement study for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]
-
Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disabilityweights measurement study for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2129-2143.
-
(2012)
Lancet
, vol.380
, Issue.9859
, pp. 2129-2143
-
-
Salomon, J.A.1
Vos, T.2
Hogan, D.R.3
-
6
-
-
84887259083
-
Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010
-
Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382 (9904):1575-1586.
-
(2013)
Lancet
, vol.382
, Issue.9904
, pp. 1575-1586
-
-
Whiteford, H.A.1
Degenhardt, L.2
Rehm, J.3
-
7
-
-
1842866942
-
Relapse in schizophrenia: Costs, clinical outcomes and quality of life
-
Almond S, Knapp M, Francois C, Toumi M, Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry. 2004; 184(4):346-351.
-
(2004)
Br J Psychiatry
, vol.184
, Issue.4
, pp. 346-351
-
-
Almond, S.1
Knapp, M.2
Francois, C.3
Toumi, M.4
Brugha, T.5
-
8
-
-
67650495255
-
Impact of psychotic relapse definitions in assessing drug efficacy and costs: Comparison of quetiapine XR, olanzapine and paliperidone ER
-
Knapp M, Locklear J, Jbrink K. Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER. Curr Med Res Opin. 2009;25(7):1593-1603.
-
(2009)
Curr Med Res Opin
, vol.25
, Issue.7
, pp. 1593-1603
-
-
Knapp, M.1
Locklear, J.2
Jbrink, K.3
-
9
-
-
84865998027
-
Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis
-
Faridi K, Joober R, Malla A. Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis. Schizophr Res. 2012;141(1):78-82.
-
(2012)
Schizophr Res
, vol.141
, Issue.1
, pp. 78-82
-
-
Faridi, K.1
Joober, R.2
Malla, A.3
-
10
-
-
78650154703
-
Rate of cannabis use disorders in clinical samples of patients with schizophrenia: Ameta-Analysis
-
Koskinen J, Len J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: Ameta-Analysis. Schizophr Bull. 2010;36(6): 1115-1130.
-
(2010)
Schizophr Bull
, vol.36
, Issue.6
, pp. 1115-1130
-
-
Koskinen, J.1
Len, J.2
Koponen, H.3
Isohanni, M.4
Miettunen, J.5
-
11
-
-
84990229660
-
-
United National Office on Drugs and Crime Washington DC United Nations Office on Drugs and Crime
-
United National Office on Drugs and Crime. World Drug Report 2015.Washington, DC: United Nations Office on Drugs and Crime; 2015.
-
(2015)
World Drug Report 2015
-
-
-
12
-
-
84959576716
-
Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-Analysis
-
Schoeler T, Monk A, Sami MB, et al. Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-Analysis. Lancet Psychiatry. 2016;3(3):215-225.
-
(2016)
Lancet Psychiatry
, vol.3
, Issue.3
, pp. 215-225
-
-
Schoeler, T.1
Monk, A.2
Sami, M.B.3
-
13
-
-
84966549733
-
Correlation still does not imply causation
-
Ksir C, Hart CL. Correlation still does not imply causation. Lancet Psychiatry. 2016;3(5):401.
-
(2016)
Lancet Psychiatry
, vol.3
, Issue.5
, pp. 401
-
-
Ksir, C.1
Hart, C.L.2
-
14
-
-
84966480792
-
Correlation still does not imply causation: Authors reply
-
Schoeler T, Murray R, Bhattacharyya S. Correlation still does not imply causation: Authors reply. Lancet Psychiatry. 2016;3(5):401-402.
-
(2016)
Lancet Psychiatry
, vol.3
, Issue.5
, pp. 401-402
-
-
Schoeler, T.1
Murray, R.2
Bhattacharyya, S.3
-
15
-
-
77955355100
-
Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization
-
Foti DJ, Kotov R, Guey LT, Bromet EJ. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry. 2010;167(8):987-993.
-
(2010)
Am J Psychiatry
, vol.167
, Issue.8
, pp. 987-993
-
-
Foti, D.J.1
Kotov, R.2
Guey, L.T.3
Bromet, E.J.4
-
16
-
-
34347234817
-
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: Findings from a 10-month prospective study
-
Degenhardt L, Tennant C, Gilmour S, et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med. 2007;37 (7):927-934.
-
(2007)
Psychol Med
, vol.37
, Issue.7
, pp. 927-934
-
-
Degenhardt, L.1
Tennant, C.2
Gilmour, S.3
-
17
-
-
77952976236
-
Psychosis reactivity to cannabis use in daily life: An experience sampling study
-
Henquet C, van Os J, Kuepper R, et al. Psychosis reactivity to cannabis use in daily life: An experience sampling study. Br J Psychiatry. 2010;196(6): 447-453.
-
(2010)
Br J Psychiatry
, vol.196
, Issue.6
, pp. 447-453
-
-
Henquet, C.1
Van Os, J.2
Kuepper, R.3
-
18
-
-
84908504595
-
Genetic predisposition to schizophrenia associated with increased use of cannabis
-
Power RA, Verweij KJ, Zuhair M, et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. 2014;19 (11):1201-1204.
-
(2014)
Mol Psychiatry
, vol.19
, Issue.11
, pp. 1201-1204
-
-
Power, R.A.1
Verweij, K.J.2
Zuhair, M.3
-
19
-
-
58349096548
-
Drawing conclusions about causes from systematic reviews of risk factors: The Cambridge Quality Checklists
-
Murray J, Farrington DP, Eisner MP. Drawing conclusions about causes from systematic reviews of risk factors: The Cambridge Quality Checklists. J Exp Criminol. 2009;5(1):1-23.
-
(2009)
J Exp Criminol
, vol.5
, Issue.1
, pp. 1-23
-
-
Murray, J.1
Farrington, D.P.2
Eisner, M.P.3
-
20
-
-
84960113186
-
Continuity of cannabis use and violent offending over the life course
-
Schoeler T, Theobald D, Pingault JB, et al. Continuity of cannabis use and violent offending over the life course. Psychol Med. 2016;46(8): 1663-1677.
-
(2016)
Psychol Med
, vol.46
, Issue.8
, pp. 1663-1677
-
-
Schoeler, T.1
Theobald, D.2
Pingault, J.B.3
-
21
-
-
84874885884
-
Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study
-
McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry. 2013;70(3):319-324.
-
(2013)
JAMA Psychiatry
, vol.70
, Issue.3
, pp. 319-324
-
-
McKetin, R.1
Lubman, D.I.2
Baker, A.L.3
Dawe, S.4
Ali, R.L.5
-
22
-
-
14944386553
-
Tests of causal linkages between cannabis use and psychotic symptoms
-
Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction. 2005;100(3):354-366.
-
(2005)
Addiction
, vol.100
, Issue.3
, pp. 354-366
-
-
Fergusson, D.M.1
Horwood, L.J.2
Ridder, E.M.3
-
23
-
-
77951853072
-
Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults
-
McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67(5): 440-447.
-
(2010)
Arch Gen Psychiatry
, vol.67
, Issue.5
, pp. 440-447
-
-
McGrath, J.1
Welham, J.2
Scott, J.3
-
24
-
-
31844443695
-
The environment and disease: Association or causation?
-
Hill AB. The environment and disease: Association or causation? Proc R Soc Med. 1965;58 (5):295-300.
-
(1965)
Proc R Soc Med
, vol.58
, Issue.5
, pp. 295-300
-
-
Hill, A.B.1
-
25
-
-
34547641049
-
Hospitalisation as an outcome measure in schizophrenia
-
Burns T. Hospitalisation as an outcome measure in schizophrenia. Br J Psychiatry Suppl. 2007;50(50):s37-s41.
-
(2007)
Br J Psychiatry Suppl
, vol.50
, Issue.50
, pp. s37-s41
-
-
Burns, T.1
-
26
-
-
84861585734
-
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-Analysis
-
Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-Analysis. Lancet. 2012;379(9831): 2063-2071.
-
(2012)
Lancet
, vol.379
, Issue.9831
, pp. 2063-2071
-
-
Leucht, S.1
Tardy, M.2
Komossa, K.3
-
27
-
-
76849096676
-
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
-
Ascher-Svanum H, Zhu B, Faries DE, et al. The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry. 2010; 10(1):2.
-
(2010)
BMC Psychiatry
, vol.10
, Issue.1
, pp. 2
-
-
Ascher-Svanum, H.1
Zhu, B.2
Faries, D.E.3
-
28
-
-
84942244171
-
Perspective: Be clear about the real risks
-
Hill M. Perspective: be clear about the real risks. Nature. 2015;525(7570):S14.
-
(2015)
Nature
, vol.525
, Issue.7570
, pp. S14
-
-
Hill, M.1
-
30
-
-
0026410654
-
A polydiagnostic application of operational criteria in studies of psychotic illness: Development and reliability of the OPCRIT system
-
McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991;48(8): 764-770.
-
(1991)
Arch Gen Psychiatry
, vol.48
, Issue.8
, pp. 764-770
-
-
McGuffin, P.1
Farmer, A.2
Harvey, I.3
-
31
-
-
84923298138
-
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study
-
Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. Lancet Psychiatry. 2015;2(3):233-238.
-
(2015)
Lancet Psychiatry
, vol.2
, Issue.3
, pp. 233-238
-
-
Di Forti, M.1
Marconi, A.2
Carra, E.3
-
32
-
-
84886075606
-
Definitions and drivers of relapse in patients with schizophrenia: A systematic literature review
-
Olivares JM, Sermon J, Hemels M, Schreiner A. Definitions and drivers of relapse in patients with schizophrenia: A systematic literature review. Ann Gen Psychiatry. 2013;12(1):32.
-
(2013)
Ann Gen Psychiatry
, vol.12
, Issue.1
, pp. 32
-
-
Olivares, J.M.1
Sermon, J.2
Hemels, M.3
Schreiner, A.4
-
33
-
-
84883196026
-
Relationship between relapse and hospitalization in first-episode psychosis
-
Addington DE, Patten SB, McKenzie E, Addington J. Relationship between relapse and hospitalization in first-episode psychosis. Psychiatr Serv. 2013;64(8):796-799.
-
(2013)
Psychiatr Serv
, vol.64
, Issue.8
, pp. 796-799
-
-
Addington, D.E.1
Patten, S.B.2
McKenzie, E.3
Addington, J.4
-
34
-
-
84863776224
-
Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-Analysis of longitudinal studies
-
Alvarez-Jimenez M, Priede A, Hetrick SE, et al. Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-Analysis of longitudinal studies. Schizophr Res. 2012;139(1-3):116-128.
-
(2012)
Schizophr Res
, vol.139
, Issue.1-3
, pp. 116-128
-
-
Alvarez-Jimenez, M.1
Priede, A.2
Hetrick, S.E.3
-
37
-
-
84933557426
-
Cannabis and psychosis: Authors reply
-
Di Forti M, Vassos E, Lynskey M, Craig M, Murray RM. Cannabis and psychosis: Authors reply. Lancet Psychiatry. 2015;2(5):382.
-
(2015)
Lancet Psychiatry
, vol.2
, Issue.5
, pp. 382
-
-
Di Forti, M.1
Vassos, E.2
Lynskey, M.3
Craig, M.4
Murray, R.M.5
-
38
-
-
84973346045
-
Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks
-
Sherva R, WangQ, Kranzler H, et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry. 2016;73(5): 472-480.
-
(2016)
JAMA Psychiatry
, vol.73
, Issue.5
, pp. 472-480
-
-
Sherva, R.1
Wang, Q.2
Kranzler, H.3
-
39
-
-
0026029607
-
Drug abuse in schizophrenic patients: Clinical correlates and reasons for use
-
Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 1991;148(2):224-230.
-
(1991)
Am J Psychiatry
, vol.148
, Issue.2
, pp. 224-230
-
-
Dixon, L.1
Haas, G.2
Weiden, P.J.3
Sweeney, J.4
Frances, A.J.5
-
40
-
-
84955469036
-
Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review
-
Wilson RP, Bhattacharyya S. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review. J Psychopharmacol. 2016;30(2):99-111.
-
(2016)
J Psychopharmacol
, vol.30
, Issue.2
, pp. 99-111
-
-
Wilson, R.P.1
Bhattacharyya, S.2
|